26
Mar, 2019
By Kelly YoungEdited by: David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD A pair of studies in JAMA Internal Medicine illustrate the difficulties of implementing lung cancer screening. In the first, eight Veterans Health Administration medical centers identified and…
READ MORE
26
Mar, 2019
Chuanli Ren, Chongxu Han Abstract China accounts for nearly half of the incidence and mortality of lung cancer in the world. Furthermore, trends in lung cancer in China are increasing younger in age and the situation is deteriorating. As a whole although screening for early lung cancer may cause a small fraction of overdiagnosis and anxiety of the population, screening for lung cancer can significantly reduce the mortality of the leading malignant disease. Large…
READ MORE
29
Nov, 2016
A supramolecular indicator displacement assay for acetyl amantadine, a proxy biomarker for spermidine/spermine N1-acetyltransferase (SSAT) activity Introduction Cancer is a leading cause of death worldwide.1 The number of new cancer cases is expected to increase 40% in the next…
READ MOREInterview with BioMark CEO Rashid Ahmed about the importance of early cancer detection and details of how the BioMark technology works. [podcast_episode episode="2159" content="title,excerpt,player"]
READ MORE